SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,489,508,540 |
| Positions | 39 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| SCHOLAR ROCK HLDG CORP | SRRK | COM | $237,110,060 | 4,311,092 |
| KRYSTAL BIOTECH INC | KRYS | COM | $234,897,298 | 632,005 |
| STOKE THERAPEUTICS INC | STOK | COM | $129,110,502 | 3,945,920 |
| IMMUNOME INC | IMNM | COM | $104,076,592 | 4,911,590 |
| NURIX THERAPEUTICS INC | NRIX | COM | $98,830,073 | 4,073,787 |
| ABSCI CORPORATION | ABSI | COM | $78,112,833 | 6,739,675 |
| ANNEXON INC | ANNX | COM | $67,776,998 | 11,869,877 |
| REGENXBIO INC | RGNX | COM | $52,338,272 | 4,368,804 |
| SHATTUCK LABS INC | STTK | COM | $47,830,709 | 6,892,033 |
| NEUROGENE INC | NGNE | COM | $44,413,659 | 1,412,199 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.